After 50 Years, Niacin Called Too Dangerous For Routine Cholesterol Therapy
Niacin has been a mainstay cholesterol therapy for 50 years but it should no longer be prescribed for most patients due to potential increased risk of death, dangerous side effects and no benefit in reducing heart attacks and strokes, according to an editorial in the New England Journal of Medicine. The editorial by Northwestern Medicine® preventive cardiologist Donald Lloyd-Jones, M.D., is based on a large new study that looked at adults, ages 50 to 80, with cardiovascular disease who took extended-release niacin (vitamin B3) and laropiprant (a drug that reduces face flushing caused by hi...